+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview



Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview



Pharmaceutical Research 28(2): 413-416



Inflammatory disorders are characterized by the influx of immune cells into the vascular wall of veins and/or arteries in response to stimuli such as oxidized-LDL and various pathogens. These factors stimulate the local production of pro-inflammatory cytokines by macrophages and other cells that promote various inflammatory diseases such as atherosclerosis, Crohn's, Alzheimer's and diabetes. Numerous cytokines play a significant role in this process, though tumor necrosis factor (TNF) and various interleukins are thought to be among the most important regulators. These proinflammatory cytokines promote the above-described diseases by inducing endothelial cell dysfunction. In this brief commentary we will discuss some of the latest advances and discoveries in the treatment of these inflammatory diseases, making use of alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonists.

(PDF emailed within 0-6 h: $19.90)

Accession: 051607987

Download citation: RISBibTeXText

PMID: 20859658

DOI: 10.1007/s11095-010-0283-7


Related references

Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies. Bioorganic & Medicinal Chemistry Letters 19(22): 6353-6357, 2010

Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain. Journal of Neurochemistry 114(4): 1205-1216, 2010

Alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators. Progress in Medicinal Chemistry 46: 131-171, 2008

Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists. Neuropharmacology 37(9): 1095-1102, 1998

Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. British Journal of Pharmacology 160(2): 322-333, 2010

Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats. Psychopharmacology 231(4): 673-683, 2014

PHARMACOLOGICAL CHARACTERISATION AND in vitro PHYSIOLOGICAL EFFECTS OF NEW alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 137 5, 2002

(+)-3-(2-(benzo(b)thiophen-2-yl)-2-oxoethyl)-1-azabicyclo(2.2.2)octane, as potent agonists for the alpha7 nicotinic acetylcholine receptor. Bioorganic and Medicinal Chemistry Letters 14(14): 3781-3784, 2004

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study. European Neuropsychopharmacology 26(9): 1401-1411, 2016

(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor. Bioorganic & Medicinal Chemistry Letters 14(14): 3781-3784, 2004

Dissociation kinetics distinguishes acetylcholine and choline as alpha7 nicotinic receptor agonists in rat hippocampal neurons. Society for Neuroscience Abstracts 26(1-2): Abstract No -716 1, 2000

In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys. Plos One 5(2): E8961-E8961, 2010

Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test station. Assay and Drug Development Technologies 7(4): 374-390, 2009

Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists. Bioorganic & Medicinal Chemistry Letters 19(16): 4747-4751, 2009

Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach. Journal of Computational Chemistry 29(15): 2593-2602, 2008